K072358 is an FDA 510(k) clearance for the BIOPLEX VASCULITIS KIT. Classified as Devices, Measure, Antibodies To Glomerular Basement Membrane (gbm) (product code MVJ), Class II - Special Controls.
Submitted by Bio-Rad Laboratories (Redmond, US). The FDA issued a Cleared decision on October 31, 2007 after a review of 70 days - a notably fast clearance cycle.
This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5660 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.